Featured Research

from universities, journals, and other organizations

New compound could become important new antidepressant

Date:
February 7, 2010
Source:
Oregon State University
Summary:
Chemists have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

A patent has been applied for on the compound, and findings on it published in the Journal of Medicinal Chemistry. Continued animal studies and eventually, human clinical trials will be necessary before the compound could be approved for human medical use, researchers say.

"Based on our results so far, this promises to be one of the most effective antidepressants yet developed," said James White, a professor emeritus of chemistry at OSU. "It may have efficacy similar to some important drugs being used now, but with fewer side effects."

Early antidepressants such as tricyclic antidepressants, White said, often had undesirable effects such as constipation, dry mouth, drowsiness and hypotension, or low blood pressure. They worked by helping the body to raise levels of such neurotransmitter compounds as serotonin, norepinephrine, dopamine and others. A second generation of antidepressants, which included the drugs Prozac and Zoloft, were more selective and produced only minor side effects, but often took weeks to become effective and sometimes didn't help patients adequately.

"The prototype of the third-generation drug in this field is Cymbalta, which tries to better balance the inhibited re-uptake of serotonin and norepinephrine, further reducing side effects and offering more immediate efficacy," White said. "It's been extremely popular."

The new compound developed at OSU, however, has properties similar to Cymbalta in some ways, but in laboratory and animal studies does a better job at balancing body chemistry.

"Our compound is 10 times better than Cymbalta at inhibiting the re-uptake of norepinephine and comes close to the holy grail of a perfectly balanced antidepressant," White said. "It should produce even fewer side effects, such as concerns with constipation and hypotension. Final results, of course, won't be known until the completion of human clinical trials."

The OSU research has been supported by the National Institute of Alcoholism and Alcohol Abuse -- an agency interested in improved antidepressants, White said, because they are often used in treatment of alcoholism. The work has been done in collaboration with the University of Indiana.


Story Source:

The above story is based on materials provided by Oregon State University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon State University. "New compound could become important new antidepressant." ScienceDaily. ScienceDaily, 7 February 2010. <www.sciencedaily.com/releases/2010/02/100204144821.htm>.
Oregon State University. (2010, February 7). New compound could become important new antidepressant. ScienceDaily. Retrieved April 19, 2014 from www.sciencedaily.com/releases/2010/02/100204144821.htm
Oregon State University. "New compound could become important new antidepressant." ScienceDaily. www.sciencedaily.com/releases/2010/02/100204144821.htm (accessed April 19, 2014).

Share This



More Health & Medicine News

Saturday, April 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Little Progress Made In Fighting Food Poisoning, CDC Says

Little Progress Made In Fighting Food Poisoning, CDC Says

Newsy (Apr. 18, 2014) A new report shows rates of two foodborne infections increased in the U.S. in recent years, while salmonella actually dropped 9 percent. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins